|
NAVKVVEEKAFSPEV
|
Gag(153-168)
|
human epitope
|
-AwVKaiEEKAFSPEV
|
Gag(153-168)
|
susceptible form
|
-AwVKVVEEKgFnPEV
|
Gag(153-168)
|
susceptible form
|
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172)
|
B57 human epitope
|
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172)
|
B57 human epitope
|
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172)
|
B57 human epitope
|
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172)
|
human epitope
|
NAWVKVVEEKAFSPEVIPMF
|
Gag(153-172)
|
macaque epitope
|
NAWVKVVEEKAFSPEVIPMFSA
|
Gag(153-174)
|
B57 human epitope
|
AWVKVIEEKAFSPEV
|
Gag(154-168)
|
human epitope
|
nAWVKVvEEKAFSPE
|
Gag(154-168)
|
subtype-specific non-susceptible form
|
AWVKVVEEKGFNPEV
|
Gag(154-168)
|
human epitope
|
nA-VKVVEEKaFsPEV
|
Gag(154-168)
|
susceptible form
|
AWVKaiEEKaFsPEV
|
Gag(154-168)
|
susceptible form
|
AWVKAIEEKAFSPEV
|
Gag(154-168)
|
human epitope
|
nA-VKvvEEKAFSPEV
|
Gag(154-168)
|
susceptible form
|
AWVKvvEEKgFnPEV
|
Gag(154-168)
|
susceptible form
|
AWVKVVEEKGFNPEV
|
Gag(154-168)
|
human epitope
|
WVKVIEEKAFSPEVIPMF
|
Gag(155-172)
|
C*16 human epitope
|
WVKVIEEKAFSPEVIPMF
|
Gag(155-172)
|
human epitope
|
WVKVIEEKAFSPEVIPMF
|
Gag(155-172)
|
human epitope
|
VKVIEEKAFSPEVIP
|
Gag(156-170)
|
human epitope
|
VKVIEEKAFSPEVIPMFT
|
Gag(156-173)
|
human epitope
|
KVVEEKAFSPEVIPM
|
Gag(157-171)
|
B44 human epitope
|
KVVEEKAFSPEVIPM
|
Gag(157-171)
|
B*57:01, B*57:03 human epitope
|
KVVEEKAFSPEVIPM
|
Gag(157-171)
|
human epitope
|
KVVEEKAFSPEVIPM
|
Gag(157-171)
|
human epitope
|
KVVEEKAFSPEVIPM
|
Gag(157-171)
|
human epitope
|
VIEEKAFSPEVIPMF
|
Gag(158-172)
|
human epitope
|
VvEEKgFnPEVIPMF
|
Gag(158-172)
|
subtype-specific susceptible form
|
VVEEKAFSPEVIPMFSALS
|
Gag(158-176)
|
macaque epitope
|
IEEKAFSPEV
|
Gag(159-168)
|
human epitope
|
IEEKAFSPEVI
|
Gag(159-169)
|
B*45:01 human epitope
|
IEEKAFSPEVI
|
Gag(159-169)
|
B*45:01, B*57:01, B*57:03 human epitope
|
MEEKAFSPEVIPMFT
|
Gag(159-173)
|
human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
A*30 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*14 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*35:01, B*35:08 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*39 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*42:01 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*44, B*44:15, B*45:01 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B44 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*44:15 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*44:15 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*45:01 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*45:01 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
B*81 human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
human epitope
|
EEKAFSPEV
|
Gag(160-168)
|
human epitope
|
EEKAFSPEVIP
|
Gag(160-170)
|
B*57 human epitope
|
EEKAFSPEVIPMFSA
|
Gag(160-174)
|
human epitope
|
EEKAFSPEVIPMFSA
|
Gag(160-174)
|
human epitope
|
EEKAFSPEVIPMFSA
|
Gag(160-174)
|
human epitope
|
EEKgFnPEVIPMFSA
|
Gag(160-174)
|
susceptible form
|
-EKgFSPEVIPMFtAL
|
Gag(160-174)
|
susceptible form
|
EEKGFNPEVIPMFSA
|
Gag(160-174)
|
human epitope
|
EEKaFsPEVIPMFSA
|
Gag(160-174)
|
susceptible form
|
-EKGFsPEVIPMFtAL
|
Gag(160-174)
|
susceptible form
|
EEKAFSPEVIPMFSALSEGA
|
Gag(160-179)
|
B27 human epitope
|
EKAFSPEV
|
Gag(161-168)
|
B*44, B*44:15, B*45:01 human epitope
|
EKAFSPEV
|
Gag(161-168)
|
human epitope
|
EKAFSPEVIPM
|
Gag(161-171)
|
macaque epitope
|
{D}KAFSPEVIPMF
|
Gag(161-172)
|
B*57:03 human epitope
|
{e}KAFSPEVIPMF
|
Gag(161-172)
|
HLA association
|
EKAFSPEVIPMF
|
Gag(161-172)
|
B*57:03, B*58:01 human epitope
|
dKAFSPEVIPMF
|
Gag(161-172)
|
HLA association
|
EKsFSPEVIPMF
|
Gag(161-172)
|
HLA association
|
EKAFnPEVIPMF
|
Gag(161-172)
|
HLA association
|
EKgFSPEVIPMF
|
Gag(161-172)
|
HLA association
|
EKAFkPEVIPMF
|
Gag(161-172)
|
HLA association
|
EKAFSPEVIPMFSAL
|
Gag(161-175)
|
human epitope
|
EKGFSPEVIPMFTAL
|
Gag(161-175)
|
human epitope
|
EEKaFSPEVIPMFsA
|
Gag(161-175)
|
susceptible form
|
EEKGFnPEVIPMFsA
|
Gag(161-175)
|
susceptible form
|
EKAFSPEVIPMFSAL
|
Gag(161-175)
|
human epitope
|
EKAFSPEVIPMFSAL
|
Gag(161-175)
|
human epitope
|
EKGFNPEVIPMFSAL
|
Gag(161-175)
|
human epitope
|
EKAFSPEVIPMFSALSEGAT
|
Gag(161-180)
|
B*57:01 human epitope
|
EKAFSPEVIPMFTALSEGAT
|
Gag(161-180)
|
human epitope
|
KAFSPEVI
|
Gag(162-169)
|
B*57 human epitope
|
KAFSPEVI
|
Gag(162-169)
|
B*57 human epitope
|
KAFSPEVI
|
Gag(162-169)
|
B*57 human epitope
|
KAFSPEVI
|
Gag(162-169)
|
B*57, B*57:01, B*57:03 human epitope
|
KAFSPEVI
|
Gag(162-169)
|
B57 human epitope
|
KAFSPEVI
|
Gag(162-169)
|
B*57:03 human epitope
|
KAFSPEVI
|
Gag(162-169)
|
B*57:03 human epitope
|
KAFSPEVI
|
Gag(162-169)
|
B*57:03 human epitope
|
KAFSPEVI
|
Gag(162-169)
|
human epitope
|
KAFSPEVI
|
Gag(162-169)
|
human epitope
|
RAFSPEVIP
|
Gag(162-170)
|
B57 human epitope
|
KAFSPEVIP
|
Gag(162-170)
|
human epitope
|
KAFSPEVIPM
|
Gag(162-171)
|
C*03:04 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*48:01, B*57:03 epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSaEVIPMF
|
Gag(162-172)
|
TCR related mutation
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KGFNPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KGFNPEVvPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KgFSPEVIPMF
|
Gag(162-172)
|
HLA association; escape documented in this paper; non-susceptible form
|
KnFSPEVIPMF
|
Gag(162-172)
|
HLA association; escape documented in this paper; non-susceptible form
|
KgFnPEVIPMF
|
Gag(162-172)
|
HLA association; escape documented in this paper; non-susceptible form
|
KgFkPEVIPMF
|
Gag(162-172)
|
HLA association; diminished HLA binding or increased off-rate; escape documented in this paper; non-susceptible form
|
KsFSPEtIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEiIPMF
|
Gag(162-172)
|
observed variant
|
KAFnPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF{t}
|
Gag(162-172)
|
literature escape; non-susceptible form; susceptible form
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
aAFSPEVIPMF
|
Gag(162-172)
|
susceptible form
|
KAaSPEVIPMF
|
Gag(162-172)
|
diminished response
|
KAFaPEVIPMF
|
Gag(162-172)
|
susceptible form
|
KAFSaEVIPMF
|
Gag(162-172)
|
diminished response
|
KAFSPaVIPMF
|
Gag(162-172)
|
diminished response
|
KAFSPEaIPMF
|
Gag(162-172)
|
diminished response
|
KAFSPEVaPMF
|
Gag(162-172)
|
diminished response
|
KAFSPEVIaMF
|
Gag(162-172)
|
diminished response
|
KAFSPEVIPaF
|
Gag(162-172)
|
susceptible form
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KnFSPEVIPMF
|
Gag(162-172)
|
diminished HLA binding or increased off-rate; literature escape
|
rAFSPEiIPMF
|
Gag(162-172)
|
diminished HLA binding or increased off-rate; literature escape
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57, B*57:01, B*57:03, B*58, B*58:01, B*63 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57, B*58 epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57, B*58:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57, B*58:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57, B*58:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57, B*58:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KvFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
eAFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KtFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57, B58 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57, B58 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*58:01, B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*58:01, B57 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B57, B63 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
rAFSPEVIPMF
|
Gag(162-172)
|
susceptible form
|
KnFSPEVIPMF
|
Gag(162-172)
|
non-susceptible form; susceptible form
|
KgFSPEVIPMF
|
Gag(162-172)
|
susceptible form
|
KAFSPEiIPMF
|
Gag(162-172)
|
susceptible form
|
KAFnPEVIPMF
|
Gag(162-172)
|
non-susceptible form; susceptible form
|
KgFnPEVIPMF
|
Gag(162-172)
|
non-susceptible form; susceptible form
|
KAFnPEiIPMF
|
Gag(162-172)
|
non-susceptible form; susceptible form
|
KAFSPgVIPMF
|
Gag(162-172)
|
non-susceptible form
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KGFNPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
{k}KAFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
{d}KAFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF{a}
|
Gag(162-172)
|
observed variant
|
{q}KAFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
{s}KAFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
{t}KAFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
{a}KAFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFaPEVIPMF{t}
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF{g}
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF{t}
|
Gag(162-172)
|
observed variant
|
rAFSPEVIPMF{a}
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF{n}
|
Gag(162-172)
|
observed variant
|
KnFSPEVIPMF{v}
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF{q}
|
Gag(162-172)
|
observed variant
|
KnFSPEVIPMF{t}
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF{v}
|
Gag(162-172)
|
observed variant
|
rAFSPEVIPMF{t}
|
Gag(162-172)
|
observed variant
|
KAFaPEVIPMF{q}
|
Gag(162-172)
|
observed variant
|
rAFSPEVIPMF{q}
|
Gag(162-172)
|
observed variant
|
KAFSPEVvPMF{a}
|
Gag(162-172)
|
observed variant
|
KAFaPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSaEVvPMF
|
Gag(162-172)
|
observed variant
|
KnFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFqPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEiIPMF
|
Gag(162-172)
|
observed variant
|
rAFSPEiIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEtIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVvPMF
|
Gag(162-172)
|
observed variant
|
rAFaPEVIPMF
|
Gag(162-172)
|
observed variant
|
rAFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
rgFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFcPEVIPMF
|
Gag(162-172)
|
observed variant
|
KqFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFtPEVIPMF
|
Gag(162-172)
|
observed variant
|
KgFaPEVIPMF
|
Gag(162-172)
|
observed variant
|
KgFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSaEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFmPEVIPMF
|
Gag(162-172)
|
observed variant
|
KgFqPEVIPMF
|
Gag(162-172)
|
observed variant
|
KeFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KsFSPEtIPMF
|
Gag(162-172)
|
observed variant
|
KdFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KsFSPEVIPfF
|
Gag(162-172)
|
observed variant
|
KgFrPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEcIPMF
|
Gag(162-172)
|
observed variant
|
KAFnPEVIPMF
|
Gag(162-172)
|
observed variant
|
KsFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFvPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEcvPMF
|
Gag(162-172)
|
observed variant
|
KtFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KcFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMs
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMt
|
Gag(162-172)
|
observed variant
|
KAFSPEiIPMF
|
Gag(162-172)
|
observed variant
|
KAsSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMs
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMt
|
Gag(162-172)
|
observed variant
|
KAFSPEiIPMF
|
Gag(162-172)
|
observed variant
|
KAsSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KsFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KgFnPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:02, B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KgFSPEVIPMF
|
Gag(162-172)
|
literature escape; replicative capacity reduced; subtype-specific non-susceptible form
|
KAFnPEVIPMF
|
Gag(162-172)
|
literature escape; replicative capacity reduced; subtype-specific non-susceptible form
|
KgFnPEVIPMF
|
Gag(162-172)
|
literature escape; replicative capacity reduced; subtype-specific non-susceptible form
|
KAFSPEVIPMF{t}
|
Gag(162-172)
|
literature escape; replicative capacity reduced; subtype-specific non-susceptible form
|
KsFSPEiIPMF
|
Gag(162-172)
|
observed variant
|
KsFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFkPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEiIPMF
|
Gag(162-172)
|
observed variant
|
KAFnPEVIPMF{i}
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF{a}
|
Gag(162-172)
|
observed variant
|
KgFnPEVIPMF{a}
|
Gag(162-172)
|
observed variant
|
KAFSPEiIPMF{t}
|
Gag(162-172)
|
observed variant
|
KsFSPEVIPMF{t}
|
Gag(162-172)
|
observed variant
|
KnFSPEVIPMF{t}
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KgFnPEVIPMF
|
Gag(162-172)
|
observed variant
|
KnFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KsFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KgFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KgFkPEVIPMF
|
Gag(162-172)
|
observed variant
|
KsFSPEtIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KgFnPEVIPMF
|
Gag(162-172)
|
subtype-specific non-susceptible form; subtype-specific susceptible form
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KgFSPEVIPMF
|
Gag(162-172)
|
subtype-specific non-susceptible form; subtype-specific susceptible form
|
KnFSPEVIPMF
|
Gag(162-172)
|
subtype-specific non-susceptible form; subtype-specific susceptible form
|
KsFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KgFnPEVIPMF
|
Gag(162-172)
|
diminished HLA binding or increased off-rate; subtype-specific non-susceptible form; subtype-specific susceptible form
|
KgFkPEVIPMF
|
Gag(162-172)
|
diminished HLA binding or increased off-rate; subtype-specific non-susceptible form; subtype-specific susceptible form
|
KsFSPEtIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEiIPMF
|
Gag(162-172)
|
subtype-specific susceptible form
|
KsFSPEiIPMF
|
Gag(162-172)
|
observed variant
|
KAFnPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFnPEiIPMF
|
Gag(162-172)
|
observed variant
|
rAFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPkVIPMF
|
Gag(162-172)
|
observed variant
|
KAlSPEVIPMF
|
Gag(162-172)
|
susceptible form
|
KAFSPEVIPvF
|
Gag(162-172)
|
susceptible form
|
KAFSqEVIPMF
|
Gag(162-172)
|
non-susceptible form
|
KAFSPEaIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KgFnPEVIPMF
|
Gag(162-172)
|
subtype-specific susceptible form
|
KAlSPEVIPMF
|
Gag(162-172)
|
subtype-specific susceptible form
|
KAFSPEVIPvF
|
Gag(162-172)
|
subtype-specific susceptible form
|
KAFnPEiIPMF
|
Gag(162-172)
|
subtype-specific susceptible form
|
KAFSPEiIPMF
|
Gag(162-172)
|
subtype-specific susceptible form
|
KAFSqEVIPMF
|
Gag(162-172)
|
diminished response; subtype-specific susceptible form
|
rgFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
rgsSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:01, B*57:03 human epitope
|
KgFSPEVIPMF
|
Gag(162-172)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper; replicative capacity reduced
|
KgFnPEVIPMF
|
Gag(162-172)
|
compensatory mutation; escape documented in this paper; replicative capacity reduced
|
KsFSPEVIPMF
|
Gag(162-172)
|
diminished HLA binding or increased off-rate; diminished response; escape documented in this paper; replicative capacity reduced
|
KxFkPEVIPMF
|
Gag(162-172)
|
compensatory mutation; escape documented in this paper
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KnFSPEVIPMF
|
Gag(162-172)
|
non-susceptible form; susceptible form
|
rAFSPEVIPMF
|
Gag(162-172)
|
non-susceptible form; susceptible form
|
KgFnPEVIPMF
|
Gag(162-172)
|
non-susceptible form; susceptible form
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KxFSPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFxPEVIPMF
|
Gag(162-172)
|
observed variant
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*57:03 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B58 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B58 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B58 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*58:01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
B*63 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
C*01 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
C*14 human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEIIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEvIPMF
|
Gag(162-172)
|
susceptible form
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEVIPMF
|
Gag(162-172)
|
human epitope
|
KAFSPEiIPMF
|
Gag(162-172)
|
susceptible form
|
AFSPEVIPMFT
|
Gag(163-173)
|
human epitope
|
AFSPEVIPMFSALS
|
Gag(163-176)
|
human epitope
|
AFSPEVIPMFTALSE
|
Gag(163-177)
|
human epitope
|
AFSPEVIPMFTALSE
|
Gag(163-177)
|
human epitope
|
AFSPEVIPMFTALSEGA
|
Gag(163-179)
|
C*14 human epitope
|
AFSPEVIPMFSALSEGA
|
Gag(163-179)
|
human epitope
|
AFSPEVIPMFtALSEGA
|
Gag(163-179)
|
subtype-specific susceptible form
|
AFSPEVIPMFSALSEGA
|
Gag(163-179)
|
human epitope
|
AFSPEVIPMFSALSEGA
|
Gag(163-179)
|
human epitope
|
AFSPEVIPMFSALSEGATPQ
|
Gag(163-182)
|
human epitope
|
AFSPEVIPMFSALSEGATPQ
|
Gag(163-182)
|
human epitope
|
AFSPEVIPMFSALSEGATPQ
|
Gag(163-182)
|
human epitope
|
AFSPEVIPMFSALSEGATPQ
|
Gag(163-182)
|
human epitope
|
FSPEVIPMF
|
Gag(164-172)
|
B*57 human epitope
|
FSPEVIPMF
|
Gag(164-172)
|
B*57 human epitope
|
FSPEVIPMF
|
Gag(164-172)
|
B*57, B*58, B*63 human epitope
|
FSPEVIPMF
|
Gag(164-172)
|
B57 human epitope
|
FSPEVIPMF
|
Gag(164-172)
|
B57, B58, B63 human epitope
|
FSPEVIPMF
|
Gag(164-172)
|
C*14 human epitope
|
FSPEVIPMF
|
Gag(164-172)
|
Mamu-A*01 macaque epitope
|
FnPEVIPMF
|
Gag(164-172)
|
susceptible form
|
FSPEiIPMF
|
Gag(164-172)
|
susceptible form
|
qSPEVIPMF
|
Gag(164-172)
|
susceptible form
|
FnPEiIPMF
|
Gag(164-172)
|
susceptible form
|
FnPEiIPMF
|
Gag(164-172)
|
susceptible form
|
FSPqVIPMF
|
Gag(164-172)
|
susceptible form
|
FSPEVIPMF
|
Gag(164-172)
|
human epitope
|
FSPEVIPMF
|
Gag(164-172)
|
human epitope
|
FSPEVIPMFS
|
Gag(164-173)
|
C*03:04 human epitope
|
FSPEVIPMFSALSEGATP
|
Gag(164-181)
|
human epitope
|
FSPEVIPMFSALSEGATP
|
Gag(164-181)
|
human epitope
|
SPEVIPMF
|
Gag(165-172)
|
human epitope
|
SPEVIPMFSALSEGA
|
Gag(165-179)
|
A2 human epitope
|
SPEVIPMFSALSEGA
|
Gag(165-179)
|
human epitope
|
SPEVIPMFSALSEGA
|
Gag(165-179)
|
mouse epitope
|
SPEVIPMFSALSEGA
|
Gag(165-179)
|
human epitope
|
PEVIPMFSAL
|
Gag(166-175)
|
C*03:04 human epitope
|
PEVIPMFaAL
|
Gag(166-175)
|
observed variant
|
PEVIPMFmAL
|
Gag(166-175)
|
observed variant
|
PEVIPMFtAL
|
Gag(166-175)
|
observed variant
|
PEVIPMFSALSEGATP
|
Gag(166-181)
|
epitope
|
PEVIPMFSALSEGATPQDLNTMLN
|
Gag(166-189)
|
human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A*25 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A*26 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A*26 human epitope
|
EVIPMFTAL
|
Gag(167-175)
|
A*26 human epitope
|
EiIPMFTAL
|
Gag(167-175)
|
observed variant
|
EVIPMFTAL
|
Gag(167-175)
|
A*26, A*26:01, A*26:02, A*26:03, C*01, C*01:02 human epitope
|
EVIPMFsAL
|
Gag(167-175)
|
HLA association; processing
|
EVIPMFSAL
|
Gag(167-175)
|
A*26, A*26:01, A*26:02, A*26:03, C*01, C*01:02 human epitope
|
EVIPMFtAL
|
Gag(167-175)
|
HLA association; processing
|
EVIPMFSAL
|
Gag(167-175)
|
A26 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A26 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A26 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A26 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A26 human epitope
|
EVIPMFTAL
|
Gag(167-175)
|
A*26:01 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A*26:01 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A*26:01 human epitope
|
EVIPMFaAL
|
Gag(167-175)
|
observed variant
|
EVIPMFtAL
|
Gag(167-175)
|
observed variant
|
EVIPMFSAL
|
Gag(167-175)
|
A*26:01 epitope
|
EVIPMFTAL
|
Gag(167-175)
|
A*26:01 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A*26:01, A*26:02, A*26:03 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A*26:01, A*26:02, A*26:03 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A*26:01, A*26:03 human epitope
|
EVIPMFaAL
|
Gag(167-175)
|
escape documented in this paper; TCR related mutation
|
EVIPMFtAL
|
Gag(167-175)
|
escape documented in this paper; TCR related mutation
|
kVIPMFSAL
|
Gag(167-175)
|
diminished HLA binding or increased off-rate
|
EiIPMFSAL
|
Gag(167-175)
|
observed variant
|
EVIPvFSAL
|
Gag(167-175)
|
observed variant
|
gVIPMFSAL
|
Gag(167-175)
|
observed variant
|
EgIPMFSAL
|
Gag(167-175)
|
observed variant
|
EVIPMFpAL
|
Gag(167-175)
|
observed variant
|
EiIPMFaAL
|
Gag(167-175)
|
observed variant
|
EmIPMFaAL
|
Gag(167-175)
|
observed variant
|
EVIPMFttL
|
Gag(167-175)
|
observed variant
|
EiIPMFtAL
|
Gag(167-175)
|
observed variant
|
EeIPMFtAL
|
Gag(167-175)
|
observed variant
|
EVIPiFtAL
|
Gag(167-175)
|
observed variant
|
EVIPvFtAL
|
Gag(167-175)
|
observed variant
|
EiIPiFtAL
|
Gag(167-175)
|
observed variant
|
EVIPMFSAL
|
Gag(167-175)
|
A*26:02 epitope
|
EVIPMFSAL
|
Gag(167-175)
|
A*26:03 epitope
|
EVIPMFTAL
|
Gag(167-175)
|
A*26:38 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
C*01 human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
human epitope
|
EVIPMFAAL
|
Gag(167-175)
|
human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
human epitope
|
EVIPMFSAL
|
Gag(167-175)
|
human epitope
|
EVIPMFTALSEGATP
|
Gag(167-181)
|
human epitope
|
EVIPMFSALSEGATP
|
Gag(167-181)
|
human epitope
|
VIPMFSAL
|
Gag(168-175)
|
B*15:16 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
B*18 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
C*01 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
C*01 human epitope
|
VIPMSFAL
|
Gag(168-175)
|
C*01:02 human epitope
|
VIPMtFAL
|
Gag(168-175)
|
HLA association; diminished response; escape documented in this paper
|
VIPMFSAL
|
Gag(168-175)
|
C*01:02 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
C*01:02 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
C*01:02 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
C*01:02 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
C*01:02 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
C*01:02 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
C*01:02 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
C*14 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
Cw1 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
Cw1 human epitope
|
VIPMFSAL
|
Gag(168-175)
|
Cw1, Cw2 human epitope
|
VIPMFAAL
|
Gag(168-175)
|
human epitope
|
VIPMFSAL
|
Gag(168-175)
|
human epitope
|
VIPMFSAL
|
Gag(168-175)
|
human epitope
|
VIPMFSAL
|
Gag(168-175)
|
human epitope
|
VIPMFSAL
|
Gag(168-175)
|
human epitope
|
VIPMFSALS
|
Gag(168-176)
|
human epitope
|
VIPMFSALSEGATPQDLN
|
Gag(168-185)
|
human, macaque epitope
|
VIPMFSALSEGATPQDLN
|
Gag(168-185)
|
mouse epitope
|
VIPMFtALSEGATPQDLN
|
Gag(168-185)
|
subtype-specific susceptible form
|
VIPMFTALSEGATPQDLN
|
Gag(168-185)
|
human, macaque epitope
|
VIPMFSALSEGATPQDLN
|
Gag(168-185)
|
macaque epitope
|
IPMFSALSEG
|
Gag(169-178)
|
B7 human epitope
|
IPMFSALSEGATPQD
|
Gag(169-183)
|
A2, B44 human epitope
|
IPMFSALSEGATPQDL
|
Gag(169-184)
|
B12 human epitope
|
IPMFSALSEGATPQDL
|
Gag(169-184)
|
B44 human epitope
|
IPMFSALSEGATPDQL
|
Gag(169-184)
|
B44 human epitope
|
PMFSALSEG
|
Gag(170-178)
|
human epitope
|
PMFTALSEGAT
|
Gag(170-180)
|
human epitope
|
PMFTALSEGATPQDLNTM
|
Gag(170-187)
|
C*08 human epitope
|
PMFSALSEGATPQDLNTM
|
Gag(170-187)
|
human epitope
|
PMFSALSEGATPQDLNTM
|
Gag(170-187)
|
human epitope
|
PMFSALSEGATPQDLNTM
|
Gag(170-187)
|
human epitope
|
PMFtALSEGATPQDLNTM
|
Gag(170-187)
|
subtype-specific susceptible form
|
PMFSALSEGATPQDLNMM
|
Gag(170-187)
|
human epitope
|
MFSALSEGA
|
Gag(171-179)
|
H-2d mouse epitope
|
MFSALSEGATPHDLN
|
Gag(171-185)
|
human epitope
|
MFTALSEGATPQDLNTMLNT
|
Gag(171-190)
|
human epitope
|
FSALSEGAT
|
Gag(172-180)
|
human epitope
|
FSALSEGATPQDLNT
|
Gag(172-186)
|
human epitope
|
TALSEGATP
|
Gag(173-181)
|
E*01:03 human epitope
|
SALSEGATPQDLNTM
|
Gag(173-187)
|
B44 human epitope
|
SALSEGATPQDLNTM
|
Gag(173-187)
|
human epitope
|
SALSEGATPQDLNTML
|
Gag(173-188)
|
human epitope
|
SALSEGATPQDLNMMLNIVG
|
Gag(173-192)
|
B*81:01 human epitope
|
SALSEGATPQDLNtMLNtVG
|
Gag(173-192)
|
observed variant
|
SALSEGATPQDLNTMLNTVG
|
Gag(173-192)
|
human epitope
|
SALSEGATPQDLNTMLNTVG
|
Gag(173-192)
|
human epitope
|
SALSEGATPQDLNTMLNTVG
|
Gag(173-192)
|
human epitope
|
SALSEGATPQDLNmMLNiVG
|
Gag(173-192)
|
observed variant
|
tALSEGATPQDLNTMLNTVG
|
Gag(173-192)
|
inferred escape
|
SALSEGATPQDLNTMLNTVG
|
Gag(173-192)
|
human epitope
|
SALSEGATPQDLNTMLNTVGGH
|
Gag(173-194)
|
B14 human epitope
|
ALSEGATPQDL
|
Gag(174-184)
|
human epitope
|
ALSEGATPQDLNMM
|
Gag(174-187)
|
human epitope
|
LSEGATPQD
|
Gag(175-183)
|
human epitope
|
LSEGATPQDL
|
Gag(175-184)
|
B42, B44 human epitope
|
LSEGATPQDL
|
Gag(175-184)
|
B*44:03 human epitope
|
LSEGATPQDLNTMLN
|
Gag(175-189)
|
human epitope
|